For non-small cell carcinoma of the
lung, surgery is the treatment of choice (if the cancer is resectable or the patient can
tolerate surgery. If surgery cannot be performed than radiation plus chemotherapy is used,
go here). For some cancers that
are locally advanced (growing into the chest wall) the patient may benefit from radiation
prior to surgery (see section on preOp
and NCCN on preOp.) If surgery is performed successfully, some patients may still benefit from postoperative radiation, particular if the surgical margins are involved or there has been spread to the lymph nodes (see section on PostOp radiation for early cases and for more advanced cases.) |
Overall Survival among Patients with Stage II or IIIa Non-Small-Cell Lung Cancer, According to Whether They Received Postoperative Radiotherapy Alone or Radiotherapy and Chemotherapy |
Keller N Engl J Med 2000;343:1217-22. |
Phase II Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non–Small-Cell Lung Cancer: Promising Long-Term Results of the Radiation Therapy Oncology Group—RTOG 9705 |
|
Journal of Clinical Oncology, Vol 23, No 15 (May 20), 2005: pp. 3480-3487 |